LUNGevity Foundation

Funds lung disease research in the United States through philanthropic support for investigators and patient focused projects.

LUNGevity Foundation is a US foundation focused on lung cancer, and the organization describes itself as the largest lung-cancer-focused nonprofit in the United States. Its grantmaking is aimed at translational and clinical research that can improve early detection, personalize treatment, and narrow gaps in lung-cancer outcomes.

The current award set runs through the Career Development Award, the Health Equity and Inclusiveness Research Fellow Award, the VA Research Scholar Award, the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant, and the RTFCCR/LUNGevity Award for Overcoming Treatment Resistance. Awards range from $50,000 seed grants to $1 million over four years, with several programs targeting early-career investigators, postdoctoral fellows, and VA-system researchers.

Applications move through proposalCENTRAL or SmartSimple, and several calls begin with a letter of intent before full review by the Scientific Advisory Board. LUNGevity pairs independent awards with partner-backed programs such as ASTRO and the Rising Tide Foundation for Clinical Cancer Research, which gives the foundation a practical route into radiation oncology, treatment-resistance research, and equity-focused lung-cancer work.